Also trades as: DXRX.L (LSE) · $vol 1M
DIUXF OTC
Diaceutics PLC
1W: +15.5%
1M: +15.5%
3M: +15.5%
YTD: +68.6%
1Y: +68.6%
3Y: +68.6%
5Y: +53.0%
$2.31
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$32M
+35.7% ▲
5Y CAGR: +19.1%
Gross Profit
$28M
+43.5% ▲
5Y CAGR: +22.4%
Operating Income
-$2M
+18.7% ▲
Net Income
-$2M
+2.5% ▲
EPS (Diluted)
$-0.02
+2.4% ▲
EBITDA
$3M
+15.5% ▲
5Y CAGR: +26.8%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $13M | $14M | $20M | $24M | $32M |
| YoY Growth | -5.6% | +9.8% | +39.9% | +21.5% | +35.7% |
| Cost of Revenue | $3M | $3M | $5M | $4M | $4M |
| Gross Profit | $9M | $11M | $14M | $20M | $28M |
| Gross Margin | 73.5% | 75.8% | 72.0% | 83.2% | 87.9% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $10M | $10M | $14M | $23M | $31M |
| Operating Expenses | $10M | $10M | $14M | $23M | $31M |
| Operating Income | -$610K | $313K | $331K | -$3M | -$2M |
| Operating Margin | -4.8% | 2.2% | 1.7% | -12.7% | -7.6% |
| Interest Expense | $51K | $88K | $122K | $66K | $54K |
| Income Before Tax | -$929K | $293K | $478K | -$2M | -$2M |
| Tax Expense | -$1M | -$268K | -$246K | -$692K | -$205K |
| Net Income | $263K | $561K | $724K | -$2M | -$2M |
| Net Margin | 2.1% | 4.0% | 3.7% | -7.4% | -5.3% |
| EPS (Diluted) | $0.00 | $0.01 | $0.01 | $-0.02 | $-0.02 |
| EBITDA | $178K | $2M | $4M | $2M | $3M |
| Shares Outstanding | 78M | 85M | 86M | 84M | 84M |